Results-oriented Research Biologist/Pharmacologist with extensive experience in Oncology and Neuroscience drug discovery. Team/Project Leader of multiple programs including full-phase, early discovery and target identification/validation. Research focus is development and use of complex cellular models to identify or validate targets and elucidate pharmacology/mechanism-of-action across multiple target classes. Interested in opportunities where my scientific experience, strong project/people management skills and passion for science can be leveraged in providing solutions to achieve organization goals. KEY ACCOMPLISHMENTS• Progressed GSK3 inhibitor program from Early through Full-phase Discovery by development of innovative strategy and novel assays as Biology Program Chair.• Advanced γ-secretase inhibitor to clinical trials through development and implementation of cell models critical to understanding compound pharmacology.• Delivered four targets into Early Discovery programs and facilitated data-driven termination of additional targets as strategy leader/coordinator of multiple target validation teams. • Facilitated progression of multiple programs through Discovery decision points by establishment of primary neuronal platform at BMS and development of novel assays in primary neuronal and mixed cultures.
Retired
-
RetiredRetired Apr 2016 - PresentTampa/St. Petersburg, Florida Area
-
Principal ScientistStaten Biotechnology/Vascumab Oct 2014 - Apr 2016Branford, Ct
-
Principal ScientistBristol-Myers Squibb 2001 - Dec 2013Wallingford, CtResponsible for in vitro and in vivo pharmacology and mechanism-of-action studies focused on preclinical discovery of GSK3 and other Tau kinase inhibitors for Alzheimer’s disease.Responsible for pharmacology of gamma-secretase and beta-secretase inhibitors in cell models for Alzheimer’s disease. -
Research ScientistDupont Pharmaceuticals 1991 - 2001Wilmington, DeResponsible for pharmacology and mechanism-of-action studies in cell-based and biochemical assays focused on preclinical discovery of cyclin dependent kinase inhibitors for Oncology. -
Research AssociateUniversity Of Delaware 1989 - 1991 -
Research AssociateLouisiana State University 1983 - 1988Baton Rouge, Louisiana
Catherine Burton Education Details
-
Microbiology And Immunology -
Microbiology, General
Frequently Asked Questions about Catherine Burton
What company does Catherine Burton work for?
Catherine Burton works for Retired
What is Catherine Burton's role at the current company?
Catherine Burton's current role is Principal Scientist.
What schools did Catherine Burton attend?
Catherine Burton attended Oregon State University, Oregon State University.
Not the Catherine Burton you were looking for?
-
Catherine Burton
Raleigh-Durham-Chapel Hill Area3sas.com, aaipharma.com, hdrinc.com -
Catherine Burton
Director Of Thought Leadership Communications & Research Editor At University Of Virginia Darden School Of BusinessCharlottesville, Va3darden.virginia.edu, virginia.edu, virginia.edu1 (434) 9XXXXXXX
-
-
Catherine Odom
Charlotte, Nc1amwins.com -
4uasys.edu, asub.edu, asub.edu, asub.edu
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial